title: Safety of electroconvulsive therapy-duloxetine combination.
authors.affiliation: Acibadem University, Medical Faculty, Istanbul, Turkey. erasland@yahoo.com
authors.forename: Defne
authors.initials: D
authors.lastname: Eraslan
authors.forename: Yasin
authors.initials: Y
authors.lastname: Genc
authors.forename: Gurkan
authors.initials: G
authors.lastname: Odabasioglu
authors.forename: Berk Murat
authors.initials: BM
authors.lastname: Ergun
authors.forename: Ozgur
authors.initials: O
authors.lastname: Ozturk
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000628:therapy*; D003987:Dibenzothiazepines / Q000627:therapeutic use; D000068736:Duloxetine Hydrochloride; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069348:Quetiapine Fumarate; D059020:Suicidal Ideation; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D013876:Thiophenes; D000069348:Quetiapine Fumarate; D000068736:Duloxetine Hydrochloride